MSH|^~\&|LAB|RCH|||201911081450||ORU^R01|4103208|D|2.3|||AL|NE PID|1||RC00007229|RC7037|LABTEST^ALMONDTHINS^||20130120|F||||||||||RC000622/19|9875495454 OBR|1|34521^LAB|00026529^2510:C00008R^LAB^251019:C8^34521|522.2490^BHCG^Beta-HCG^^^21198-7||201910250903|201910250700|||||||201910250903||||||||||LAB|F|||| NTE|1||OUTSIDE LINEARITY HIGH OBX|1|ST|522.2510^BHCG R^Beta-HCG^^21198-7^21198-7|1|45139^^Y|IU/L|<10|H||A^S|F|||201911081450 NTE|1||Reference Intervals, (guideline only) FOR B-HCG (U/L): NTE|2|| NTE|3||Male or non-pregnant female Less than 10 NTE|4||Pregnant female: NTE|5||Time after LMP: Expected beta-HCG range(WHO 3rd IRP): NTE|6||4th week 25 - 426 NTE|7||5th week 25 - 7340 NTE|8||6th week 1080 - 56500 NTE|9||10th week 54100 - 288000 NTE|10||18th week 8910 - 66000 NTE|11||31st week 5310 - 27400 NTE|12||*************************NOTE******************************* NTE|13||Occasional patients with heterophile antibodies may have NTE|14||erroneous BHCG results. Serum BHCG should not be used for NTE|15||routine pregnancy tests. Urine does not contain heterophile NTE|16||antibodies and may be used where apparent discrepant results NTE|17||are experienced. NTE|18||Method:Beckman Access/DxI  MSH|^~\&|LAB|RCH|||201911081451||ORU^R01|4103209|D|2.3|||AL|NE PID|1||RC00007325|RC7134|LABTEST^AIR^UPTEMPO||19740306|M||||||||||RC000949/18|9875474973 OBR|1|34519^LAB|00026527^2510:C00006R^LAB^251019:C6^34519|500.1000^CP7^Chem 7 - Glu R,Urea,Crea,Lytes^^^XXX-1710||201910250902|201910250700|||||||201910250901||||||||||LAB|I|||| NTE|1||Outside normal low OBR|2|34519^LAB|00026527^2510:C00006R^LAB^251019:C6^34519|522.2490^BHCG^Beta-HCG^^^21198-7||201910250902|201910250700|||||||201910250901||||||||||LAB|F|||| NTE|1||Outside normal low OBX|1|ST|522.2510^BHCG R^Beta-HCG^^21198-7^21198-7|1|3476^^Y|IU/L|<10|H||A^S|F|||201911081451 NTE|1||Method:Beckman Access/DxI  MSH|^~\&|LAB|RCH|||201911081451||ORU^R01|4103210|D|2.3|||AL|NE PID|1||RC00006059|RC6052|LABTEST^ALASKA^ROLL||19900918|F||||||||||RC000620/19|9876521172 OBR|1|34518^LAB|00026526^2510:C00005R^LAB^251019:C5^34518|522.2490^BHCG^Beta-HCG^^^21198-7||201910250901|201910250700|||||||201910250900||||||||||LAB|F|||| NTE|1||Outside normal high OBX|1|ST|522.2510^BHCG R^Beta-HCG^^21198-7^21198-7|1|3213^^Y|IU/L|<10|H||A^S|F|||201911081451 NTE|1||Reference Intervals, (guideline only) FOR B-HCG (U/L): NTE|2|| NTE|3||Male or non-pregnant female Less than 10 NTE|4||Pregnant female: NTE|5||Time after LMP: Expected beta-HCG range(WHO 3rd IRP): NTE|6||4th week 25 - 426 NTE|7||5th week 25 - 7340 NTE|8||6th week 1080 - 56500 NTE|9||10th week 54100 - 288000 NTE|10||18th week 8910 - 66000 NTE|11||31st week 5310 - 27400 NTE|12||*************************NOTE******************************* NTE|13||Occasional patients with heterophile antibodies may have NTE|14||erroneous BHCG results. Serum BHCG should not be used for NTE|15||routine pregnancy tests. Urine does not contain heterophile NTE|16||antibodies and may be used where apparent discrepant results NTE|17||are experienced. NTE|18||Method:Beckman Access/DxI